Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
NCT06105931Phase 1Active, not recruiting
- Sponsor
- Yale University
- Start
- Dec 2023
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Yale University. Primary endpoints: Change in visceral adipose tissue ratio at 1 year, Change in hepatic insulin resistance at 1 year and 1 more. Started Dec 2023; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06105931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06105931.